Japan startup applies for approval of iPS cell therapy for heart disease
Clinical trials involving eight patients showed improvements in symptoms and cardiac function.
Cardiovascular
Garuda Therapeutics Nabs $50 Million Series A-1 Financing for Off-the-Shelf Blood Stem Cell Therapies
New funds aim to advance Garuda’s pipeline toward clinical trials, expand manufacturing capabilities, and support operational growth.
